Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
VCP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TBC1D7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RFWD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HOXB7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRCAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDKL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR1D5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC8A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACOT11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSD11B1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK1IP1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS26A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C2orf15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF430 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYB5RL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCHO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on